• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

效应淋巴细胞诱导的淋巴结样脉管系统使初始T细胞能够进入肿瘤并增强抗肿瘤免疫力。

Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity.

作者信息

Peske J David, Thompson Elizabeth D, Gemta Lelisa, Baylis Richard A, Fu Yang-Xin, Engelhard Victor H

机构信息

Department of Microbiology and Carter Immunology Center, University of Virginia School of Medicine, Box 801386, Charlottesville, Virginia 22901, USA.

Department of Pathology and Committee on Immunology, University of Chicago, Chicago, Illinois 60637, USA.

出版信息

Nat Commun. 2015 May 13;6:7114. doi: 10.1038/ncomms8114.

DOI:10.1038/ncomms8114
PMID:25968334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4435831/
Abstract

The presence of lymph node (LN)-like vasculature in tumours, characterized by expression of peripheral node addressin and chemokine CCL21, is correlated with T-cell infiltration and positive prognosis in breast cancer and melanoma patients. However, mechanisms controlling the development of LN-like vasculature and how it might contribute to a beneficial outcome for cancer patients are unknown. Here we demonstrate that LN-like vasculature is present in murine models of melanoma and lung carcinoma. It enables infiltration by naive T cells that significantly delay tumour outgrowth after intratumoral activation. Development of this vasculature is controlled by a mechanism involving effector CD8 T cells and NK cells that secrete LTα3 and IFNγ. LN-like vasculature is also associated with organized aggregates of B lymphocytes and gp38(+) fibroblasts, which resemble tertiary lymphoid organs that develop in models of chronic inflammation. These results establish LN-like vasculature as both a consequence of and key contributor to anti-tumour immunity.

摘要

肿瘤中存在以外周淋巴结地址素和趋化因子CCL21表达为特征的淋巴结(LN)样脉管系统,这与乳腺癌和黑色素瘤患者的T细胞浸润及良好预后相关。然而,控制LN样脉管系统发育的机制以及它如何为癌症患者带来有益结果尚不清楚。在此,我们证明在黑色素瘤和肺癌的小鼠模型中存在LN样脉管系统。它能使幼稚T细胞浸润,这些T细胞在肿瘤内激活后能显著延迟肿瘤生长。这种脉管系统的发育受一种涉及分泌LTα3和IFNγ的效应性CD8 T细胞和NK细胞的机制控制。LN样脉管系统还与B淋巴细胞和gp38(+)成纤维细胞的有组织聚集体相关,这些聚集体类似于在慢性炎症模型中发育的三级淋巴器官。这些结果确立了LN样脉管系统既是抗肿瘤免疫的结果又是其关键促成因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/4cb8ab0e2231/nihms678222f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/a93776c127e3/nihms678222f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/4e915212fc8c/nihms678222f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/6780914027b9/nihms678222f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/b75da20be94c/nihms678222f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/aa09517b57ea/nihms678222f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/d3e895cd0bae/nihms678222f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/f74ca5d1ddb3/nihms678222f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/f9130dd66355/nihms678222f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/7d585c904032/nihms678222f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/4cb8ab0e2231/nihms678222f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/a93776c127e3/nihms678222f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/4e915212fc8c/nihms678222f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/6780914027b9/nihms678222f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/b75da20be94c/nihms678222f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/aa09517b57ea/nihms678222f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/d3e895cd0bae/nihms678222f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/f74ca5d1ddb3/nihms678222f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/f9130dd66355/nihms678222f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/7d585c904032/nihms678222f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43d0/4435831/4cb8ab0e2231/nihms678222f10.jpg

相似文献

1
Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity.效应淋巴细胞诱导的淋巴结样脉管系统使初始T细胞能够进入肿瘤并增强抗肿瘤免疫力。
Nat Commun. 2015 May 13;6:7114. doi: 10.1038/ncomms8114.
2
CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.CCL21 和 IFNγ 在乳腺癌的 3D 支架模型中招募和激活肿瘤特异性 T 细胞。
Anticancer Agents Med Chem. 2014 Feb;14(2):204-10. doi: 10.2174/18715206113136660375.
3
Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment.流体流动调节组织工程淋巴结微环境中的基质细胞组织和CCL21表达。
J Immunol. 2009 Oct 1;183(7):4273-83. doi: 10.4049/jimmunol.0900835. Epub 2009 Sep 4.
4
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.促炎趋化因子-趋化因子受体相互作用在尤文肉瘤微环境中决定 CD8(+) T 淋巴细胞浸润并影响肿瘤进展。
J Pathol. 2011 Feb;223(3):347-57. doi: 10.1002/path.2819. Epub 2010 Dec 10.
5
Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor.肿瘤特异性T细胞通过淋巴毒素β受体发出肿瘤破坏信号。
J Transl Med. 2007 Mar 13;5:14. doi: 10.1186/1479-5876-5-14.
6
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth.宿主细胞中 Toll 样受体 3/7/9 的联合缺失导致 T 细胞依赖控制肿瘤生长。
Nat Commun. 2017 Mar 16;8:14600. doi: 10.1038/ncomms14600.
7
Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8+ T-cell density and activity, and enlarges draining lymph nodes.肿瘤内白细胞介素-21 增加抗肿瘤免疫、肿瘤浸润 CD8+T 细胞密度和活性,并增大引流淋巴结。
J Immunother. 2010 Apr;33(3):236-49. doi: 10.1097/CJI.0b013e3181c0c1cb.
8
Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node.癌细胞调节肿瘤引流淋巴结中的淋巴细胞募集和白细胞与内皮细胞的相互作用。
Cancer Res. 2005 Dec 15;65(24):11639-48. doi: 10.1158/0008-5472.CAN-05-1190.
9
Tumor necrosis factor receptor regulation of peripheral node addressin biosynthetic components in tumor endothelial cells.肿瘤坏死因子受体调节肿瘤内皮细胞外周节点地址素生物合成成分。
Front Immunol. 2022 Sep 15;13:1009306. doi: 10.3389/fimmu.2022.1009306. eCollection 2022.
10
Differential induction of adhesion molecule and chemokine expression by LTalpha3 and LTalphabeta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development.LTα3和LTαβ在炎症中对黏附分子和趋化因子表达的差异诱导阐明了肠系膜和外周淋巴结发育的潜在机制。
J Immunol. 1999 May 15;162(10):5965-72.

引用本文的文献

1
Targeting Melanin Heterogeneity in Metastatic Melanoma: A Dual-Tumour Mouse Melanoma Model.靶向转移性黑色素瘤中的黑色素异质性:一种双肿瘤小鼠黑色素瘤模型。
Exp Dermatol. 2025 Sep;34(9):e70159. doi: 10.1111/exd.70159.
2
In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy.深入了解与三级淋巴结构相关的肿瘤浸润性基质细胞及其在癌症免疫治疗中的潜在功能。
Exp Hematol Oncol. 2025 Aug 10;14(1):105. doi: 10.1186/s40164-025-00695-8.
3
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy.

本文引用的文献

1
Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.BRAF抑制剂基于免疫的抗肿瘤作用依赖于CD40L和IFNγ的信号传导。
Cancer Res. 2014 Jun 15;74(12):3205-17. doi: 10.1158/0008-5472.CAN-13-3461. Epub 2014 Apr 15.
2
High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.高内皮静脉血管中的肿瘤浸润淋巴细胞与人类乳腺癌中的淋巴毒素β产生树突状细胞有关。
J Immunol. 2013 Aug 15;191(4):2001-8. doi: 10.4049/jimmunol.1300872. Epub 2013 Jul 3.
3
Cognate antigen directs CD8+ T cell migration to vascularized transplants.
肿瘤相关血管在T细胞归巢与免疫中的作用:癌症治疗的机遇
Nat Rev Immunol. 2025 Jun 27. doi: 10.1038/s41577-025-01187-w.
4
Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma.干扰素反应性戊型肝炎病毒驱动鼻咽癌肿瘤三级淋巴结构形成并预测免疫治疗反应。
Cell Rep Med. 2025 Jul 15;6(7):102200. doi: 10.1016/j.xcrm.2025.102200. Epub 2025 Jun 20.
5
Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade.超越细胞毒性T细胞:重编程的调节性T细胞有助于促进对双重检查点阻断的反应。
Mol Oncol. 2025 Aug;19(8):2163-2165. doi: 10.1002/1878-0261.70076. Epub 2025 Jun 15.
6
Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade.Fc优化的抗CTLA-4抗体增加肿瘤相关的高内皮微静脉,并使难治性肿瘤对PD-1阻断敏感。
Cell Rep Med. 2025 Jun 17;6(6):102141. doi: 10.1016/j.xcrm.2025.102141. Epub 2025 Jun 3.
7
Cancer microbiota: a focus on tumor-resident bacteria.癌症微生物群:聚焦肿瘤驻留细菌。
EMBO Rep. 2025 May 28. doi: 10.1038/s44319-025-00482-w.
8
Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression.胶质瘤中的三级淋巴结构:对肿瘤免疫和进展的影响
J Transl Med. 2025 May 9;23(1):528. doi: 10.1186/s12967-025-06510-6.
9
Pipelines for lymphocyte homeostasis maintenance during cancer immunotherapy.癌症免疫治疗期间维持淋巴细胞稳态的途径。
Front Immunol. 2025 Mar 24;16:1522417. doi: 10.3389/fimmu.2025.1522417. eCollection 2025.
10
Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy.探索肠道微生物群对肿瘤免疫治疗中三级淋巴结构形成的影响。
Front Immunol. 2025 Mar 7;15:1518779. doi: 10.3389/fimmu.2024.1518779. eCollection 2024.
同源抗原指导 CD8+ T 细胞向血管化移植物迁移。
J Clin Invest. 2013 Jun;123(6):2663-71. doi: 10.1172/JCI66722. Epub 2013 May 15.
4
Endothelial cell-specific lymphotoxin-β receptor signaling is critical for lymph node and high endothelial venule formation.内皮细胞特异性淋巴毒素-β 受体信号对于淋巴结和高内皮小静脉的形成至关重要。
J Exp Med. 2013 Mar 11;210(3):465-73. doi: 10.1084/jem.20121462. Epub 2013 Feb 18.
5
High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.人类黑色素瘤病变中的高内皮小静脉 (HEVs):肿瘤浸润淋巴细胞的主要门户。
Oncoimmunology. 2012 Sep 1;1(6):829-839. doi: 10.4161/onci.20492.
6
12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?12-趋化因子基因特征可识别黑色素瘤中的淋巴结样结构:是否有助于免疫治疗患者选择?
Sci Rep. 2012;2:765. doi: 10.1038/srep00765. Epub 2012 Oct 24.
7
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes.混合动力电动汽车、淋巴管和淋巴结中稳态免疫细胞的迁移。
Nat Rev Immunol. 2012 Nov;12(11):762-73. doi: 10.1038/nri3298. Epub 2012 Sep 28.
8
T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion.高内皮静脉细胞促进的 T 细胞迁移是耗竭调节性 T 细胞后肿瘤控制所必需的。
Cancer Res. 2012 Nov 1;72(21):5473-82. doi: 10.1158/0008-5472.CAN-12-1912. Epub 2012 Sep 7.
9
Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases.人类黑色素瘤转移灶中发生淋巴样结构的新生和抗体应答。
Cancer Res. 2012 Aug 15;72(16):3997-4007. doi: 10.1158/0008-5472.CAN-12-1377. Epub 2012 Jul 31.
10
β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.β-catenin 信号通路控制着 Braf 激活 Pten 缺失型黑色素瘤的转移。
Cancer Cell. 2011 Dec 13;20(6):741-54. doi: 10.1016/j.ccr.2011.10.030.